EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-89
SponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

About this trial

In this study, the investigators hypothesize that a high dose of post-workout protein after each exercise session will have greater improvements in changes in body composition, including muscle mass and percent body fat versus a workout alone.

Eligibility criteria

Qualifiers

Age 20-89 years

Women prescribed exercise as a SOC

Women with a biopsy proven diagnosis of ductal carcinoma in situ (DCIS) or invasive carcinoma of the breast

Women must have undergone treatment for breast cancer, including one or more of the following: surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy. Women undergoing active chemotherapy are not allowed on study. Immunotherapy or targeted agent usage is allowed.

Disqualifiers

Any current treatment with cytotoxic chemotherapy for breast cancer

Inability to safely engage in group sessions of resistance training as deemed by study PI

Severe arthritic, joint, cardiovascular, or musculoskeletal condition deemed by PI to be unsafe to engage in resistance training

Beta blocker or GLP-1 inhibitor medications

Trial design

Treatments tested in this trial

  • Whey protein (60 grams)
  • No protein

Treatment groups

40 Participants
are divided into 2 treatment groups